Elephas Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 120

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $42.7M

  • Investors
  • 9

Elephas General Information

Description

Developer of live tumor diagnostic technology designed to assess patient response to immunotherapy from core needle biopsy samples before treatment initiation. The company offers a platform that integrates cancer biology, multimodal microscopy, engineering, artificial intelligence, and analysis of live human tumor fragments, enabling clinicians to inform treatment decisions for cancer patients and support drug development efforts.

Contact Information

Website
www.elephas.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Erdman Place
  • Suite 100
  • Madison, WI 53717
  • United States
+1 (608)
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • 1 Erdman Place
  • Suite 100
  • Madison, WI 53717
  • United States
+1 (608)

Elephas Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elephas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B2) 06-Nov-2025 $42.7M Completed Clinical Trials - General
4. Later Stage VC (Series B1) 08-Jan-2024 Completed Clinical Trials - General
3. Early Stage VC (Series B) 06-Sep-2022 Completed Clinical Trials - General
2. Early Stage VC (Series A) 15-Sep-2021 $21M $28M Completed Clinical Trials - General
1. Seed Round 15-May-2021 $7M $7M Completed Clinical Trials - General
To view Elephas’s complete valuation and funding history, request access »

Elephas Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series B
Series A
Seed 2 1,019,214 $0.000010 $5.89 $5.89 1x $5.89 5.26%
Seed 1 1,183,168 $0.000010 $0.85 $0.85 1x $0.85 6.11%
To view Elephas’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Elephas Patents

Elephas Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260202290-A1 Systems and methods for embedding and cutting tissue sample Pending 15-Jan-2025
WO-2026156127-A1 Systems and methods for embedding and cutting tissue sample Pending 15-Jan-2025
US-12467918-B1 Systems and methods for measuring changes in cellular activity in live tissue Active 10-Jan-2025
US-20260202396-A1 Systems and methods for measuring changes in cellular activity in live tissue Pending 10-Jan-2025
WO-2026151959-A1 Systems and methods for measuring changes in cellular activity in live tissue Pending 10-Jan-2025 G01N33/575
To view Elephas’s complete patent history, request access »

Elephas Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elephas Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clarevia Ventures Venture Capital Minority
State of Wisconsin Investment Board Government Minority
ARCH Venture Partners Venture Capital Minority
Moore Capital Management Hedge Fund Minority
Moore Strategic Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Elephas FAQs

  • When was Elephas founded?

    Elephas was founded in 2020.

  • Where is Elephas headquartered?

    Elephas is headquartered in Madison, WI.

  • What is the size of Elephas?

    Elephas has 120 total employees.

  • What industry is Elephas in?

    Elephas’s primary industry is Diagnostic Equipment.

  • Is Elephas a private or public company?

    Elephas is a Private company.

  • What is the current valuation of Elephas?

    The current valuation of Elephas is .

  • What is Elephas’s current revenue?

    The current revenue for Elephas is .

  • How much funding has Elephas raised over time?

    Elephas has raised $169M.

  • Who are Elephas’s investors?

    Clarevia Ventures, State of Wisconsin Investment Board, ARCH Venture Partners, Moore Capital Management, and Moore Strategic Ventures are 5 of 9 investors who have invested in Elephas.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process